Related Experiment Videos
[Use of phospholipids (Fibraccel) for hemostasis in thrombocytopenic-thrombocytopathic patients]
G Dietrich1, D Söhngen, V Kretschmer
1Abteilung für Transfusionsmedizin und Gerinnungsphysiologie, Philipps-Universität Marburg.
Eight thrombocytopenic/pathic patients received an intravenous infusion of phospholipids. In-vitro-bleeding test, thrombelastography and resonance thrombography were performed in order to show the hemostatic effect. There was no case in which phospholipids had an efficacy comparable to the transfusion of platelets. Two patients suffered from a severe anaphylactoid reaction after the administration of phospholipids.
Eight thrombocytopenic/pathic patients received an intravenous infusion of phospholipids. In-vitro-bleeding test, thrombelastography and resonance thrombography were performed in order to show the hemostatic effect. There was no case in which phospholipids had an efficacy comparable to the transfusion of platelets. Two patients suffered from a severe anaphylactoid reaction after the administration of phospholipids.